Subcutaneous fat transplantation alleviates diet-induced glucose intolerance and inflammation in mice

Diabetologia

Volumn 58, Issue 7, 2015, Pages 1587-1600

  Hocking, Samantha L ^a,b   Stewart, Rebecca L ^a   Brandon, Amanda E ^a   Suryana, Eurwin ^a   Stuart, Ella ^a   Baldwin, Emily M ^a   Kolumam, Ganesh A ^c   Modrusan, Zora ^c   Junutula, Jagath R ^c   Gunton, Jenny E ^d,e   Medynskyj, Michael ^f,g   Blaber, Sinead P ^f,g   Karsten, Elisabeth ^f,g   Herbert, Benjamin R ^f,g   James, David E ^a,h   Cooney, Gregory J ^a,i   Swarbrick, Michael M ^a,d,j  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c GENENTECH INC   (United States)

^d WESTMEAD HOSPITAL   (Australia)

^e University of Sydney   (Australia)

^f MACQUARIE UNIVERSITY   (Australia)

^g Regeneus Ltd   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

Adipose tissue; Body fat distribution; Fatty liver; Glucose intolerance; Inflammation; Insulin resistance; Intra abdominal fat; Obesity; Subcutaneous fat; Visceral

Indexed keywords

ADIPONECTIN; GLUCOSE; GLYCOGEN; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CONTROLLED STUDY; ENERGY EXPENDITURE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INSULINEMIA; INTRAABDOMINAL FAT; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RNA PROCESSING; SUBCUTANEOUS FAT; SUBCUTANEOUS FAT TRANSPLANTATION; TH2 CELL; TISSUE TRANSPLANTATION; ADIPOCYTE; ADVERSE EFFECTS; ANIMAL; BLOOD; BODY COMPOSITION; C57BL MOUSE; EATING; GLUCONEOGENESIS; LIVER; METABOLISM; TRANSPLANTATION; ULTRASTRUCTURE;

ADIPOCYTES; ADIPONECTIN; ADIPOSITY; ANIMALS; BODY COMPOSITION; CYTOKINES; DIET, HIGH-FAT; EATING; GLUCONEOGENESIS; GLUCOSE; GLUCOSE INTOLERANCE; INFLAMMATION; INSULIN; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; SUBCUTANEOUS FAT; TRIGLYCERIDES;

EID: 84931577296     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3583-y     Document Type: Article

References (47)

1. Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74:761–811
2. Carr DB, Utzschneider KM, Hull RL et al (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53:2087–2094
3. Bjorntorp P (1990) “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493–496
4. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity. J Clin Invest 113:1582–1588
5. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56:1010–1013
6. Manolopoulos KN, Karpe F, Frayn KN (2010) Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 34:949–959
7. Manolopoulos KN, Karpe F, Frayn KN (2012) Marked resistance of femoral adipose tissue blood flow and lipolysis to adrenaline in vivo. Diabetologia 55:3029–3037
8. Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201–1210
9. Pinnick KE, Nicholson G, Manolopoulos KN et al (2014) Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications. Diabetes 63:3785–3797
10. Swarbrick MM (2014) A lifetime on the hips: programming lower-body fat to protect against metabolic disease. Diabetes 63:3575–3577
11. Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830
12. Sun S, Ji Y, Kersten S, Qi L (2012) Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr 32:261–286
13. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808
14. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175–184
15. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18:363–374
16. Fabbrini E, Cella M, McCartney SA et al (2013) Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology 145(366–374):e361–e363
17. Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE (2010) The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 152:346–357
18. Konrad D, Rudich A, Schoenle EJ (2007) Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue. Diabetologia 50:833–839
19. Hocking SL, Chisholm DJ, James DE (2008) Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment. Diabetologia 51:900–902
20. Tran TT, Yamamoto Y, Gesta S, Kahn CR (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410–420
21. Foster MT, Shi H, Softic S, Kohli R, Seeley RJ, Woods SC (2011) Transplantation of non-visceral fat to the visceral cavity improves glucose tolerance in mice: investigation of hepatic lipids and insulin sensitivity. Diabetologia 54:2890–2899
22. Foster MT, Softic S, Caldwell J, Kohli R, de Kloet AD, Seeley RJ (2013) Subcutaneous adipose tissue transplantation in diet-induced obese mice attenuates metabolic dysregulation while removal exacerbates it. Physiol Rep 1:e00015
23. Hoehn KL, Turner N, Swarbrick MM et al (2010) Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. Cell Metab 11:70–76
24. Crosson SM, Khan A, Printen J, Pessin JE, Saltiel AR (2003) PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest 111:1423–1432
25. Lau SM, Cha KM, Karunatillake A et al (2013) Beta-cell ARNT is required for normal glucose tolerance in murine pregnancy. PLoS One 8:e77419
26. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP (2006) GenePattern 2.0. Nat Genet 38:500–501
27. Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550
28. Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267–273
29. Munoz S, Franckhauser S, Elias I et al (2010) Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse. Diabetologia 53:2417–2430
30. Clark RI, Tan SW, Pean CB et al (2013) MEF2 is an in vivo immune-metabolic switch. Cell 155:435–447
31. Reed BD, Charos AE, Szekely AM, Weissman SM, Snyder M (2008) Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet 4:e1000133
32. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8:301–309
33. Jiao P, Chen Q, Shah S et al (2009) Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 58:104–115
34. Yepuru M, Eswaraka J, Kearbey JD et al (2010) Estrogen receptor-{beta}-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem 285:31292–31303
35. Sell H, Habich C, Eckel J (2012) Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8:709–716
36. Bassaganya-Riera J, Misyak S, Guri AJ, Hontecillas R (2009) PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammation. Cell Immunol 258:138–146
37. Ohman MK, Shen Y, Obimba CI et al (2008) Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117:798–805
38. Nov O, Shapiro H, Ovadia H et al (2013) Interleukin-1beta regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability. PLoS One 8:e53626
39. Rytka JM, Wueest S, Schoenle EJ, Konrad D (2011) The portal theory supported by venous drainage-selective fat transplantation. Diabetes 60:56–63
40. Caspar-Bauguil S, Cousin B, Galinier A et al (2005) Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 579:3487–3492
41. Paz-Filho G, Mastronardi CA, Parker BJ et al (2013) Molecular pathways involved in the improvement of non-alcoholic fatty liver disease. J Mol Endocrinol 51:167–179
42. Winer S, Paltser G, Chan Y et al (2009) Obesity predisposes to Th17 bias. Eur J Immunol 39:2629–2635
43. Chuang HC, Sheu WH, Lin YT et al (2014) HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun 5:4602
44. Zuniga LA, Shen WJ, Joyce-Shaikh B et al (2010) IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol 185:6947–6959
45. Harley IT, Stankiewicz TE, Giles DA et al (2014) IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology 59:1830–1839
46. Jagannathan-Bogdan M, McDonnell ME, Shin H et al (2011) Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 186:1162–1172
47. Goossens GH, Blaak EE, Theunissen R et al (2012) Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans. Mol Immunol 50:142–149